US Signs Off on Syngenta Deal

August 23, 2016

from Boom Bust

ChemChina was cleared by national security regulators in the US for its acquisition of Syngenta; Ameera David weighs in. Then, RT’s Manuel Rapalo discuss Pfizer’s bid to purchase Medivation for $14 billion. Afterwards, Bianca Facchinei reports on new national security measures in Germany.

After the break, Ameera is joined by Peter Schiff – CEO of Euro Pacific Capital – to talk about the US economy. And in The Big Deal, Ameera and Edward Harrison discuss Jackson Hole.

Take a look!

Watch more Peter Schiff’s videos on his channel http://www.youtube.com/user/SchiffReport

Check us out on Facebook — and feel free to ask us questions:
http://www.facebook.com/BoomBustRT
https://www.facebook.com/harrison.wri…
https://www.facebook.com/biancafacch

Follow us @
https://twitter.com/AmeeraDavid
http://twitter.com/edwardnh
https://twitter.com/BiancaFacchinei

© 2024 Financial Survival Network

Financial Survival Network (FSN) content is informational only and based on information available at the time of creation. It is not an offer or solicitation, nor does it provide investment, tax, or legal advice. It may not consider your specific financial circumstances or objectives and may not be suitable for you. FSN content is not a recommendation to buy or sell any securities. Readers should consult their own professional advisers and conduct their own independent investigations before making any investment decisions. FSN does not guarantee the accuracy or completeness of its content or any third-party information it uses, which has not been independently verified by FSN. Readers are cautioned not to rely solely on FSN content for investment decisions.

FSN and its owner may have financial interests in the companies discussed and may trade such securities without prior notice. FSN is funded by sponsor advertisements, with payments ranging from five to ten thousand dollars monthly. FSN does not charge its viewers/listeners/readers any fees. By accessing FSN content, users agree that FSN and its affiliates are not liable for any inaccuracies, omissions, or representations in the content provided.